AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AMGEN INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$424.94−7.55 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $231.17B
- P/E (TTM)
- 26.4
- Dividend yield
- 2.27%
SEC filings
40 of Amgen's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 20, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 1, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 19, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Jan 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 23, 2025 | May 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 23, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2025 | Feb 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 31, 2024 | Jun 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 31, 2024 | Apr 17, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 14, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2024 | Feb 6, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2023 | Dec 14, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Oct 31, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2023 | Oct 31, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2023 | Oct 6, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2023 | Oct 5, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2023 | Sep 12, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 1, 2023 | Sep 5, 2023 | SEC EDGAR |